Brief: ATyr Pharma Announces LTBP1 As Target Of DARS TRNA Synthetase Fragment
15/12/2022 13:29
Dec 15 (Reuters) - aTyr Pharma Inc LIFE.O :
* ATYR PHARMA ANNOUNCES LTBP1 AS TARGET OF DARS TRNA
SYNTHETASE
FRAGMENT
Source text for Eikon: ID:nGNX376zhb
Further company coverage: LIFE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan